Related Experiment Video
Updated: May 9, 2026

06:39
Novel Percutaneous Approach for Deployment of 3D Printed Coronary Stenosis Implants in Swine Models of Ischemic Heart Disease
Published on: February 18, 2020
Development of a new selective coronary perfusion cannula
Nobuo Kondo1, Masaki Yamamoto, Kazuki Kihara
1Department of Surgery II, Kochi Medical School, Kohasu, Oko-cho, Nankoku, Kochi, 783-8505, Japan, jm-kondo-nobuo@kochi-u.ac.jp.
Summary
The new Kochi Medical School (KMS)-type cannula offers improved cardioplegic solution delivery compared to balloon and fenestrated types. It minimizes leakage and ensures secure infusion, especially in diseased coronary ostia.
Area of Science:
- Cardiovascular Surgery
- Medical Device Engineering
- Perfusion Technology
Background:
- Current coronary perfusion cannulae, including balloon and fenestrated types, can lead to high perfusion pressures or significant leakage during cardioplegic solution infusion.
- Addressing these limitations is crucial for optimizing myocardial protection during cardiac surgery.
Purpose of the Study:
- To evaluate the performance of a newly developed Kochi Medical School (KMS)-type coronary perfusion cannula.
- To compare the KMS-type cannula against traditional balloon and fenestrated types in an ex vivo model.
Main Methods:
- An ex vivo experimental model with varying ostium sizes (4, 3, 2 mm) was used.
- Ejected flow velocity, circuit pressure, and leakage were measured at infusion rates of 100 and 200 mL/min.
- Measurements were taken under zero and 50 cmH2O counterpressure to simulate different coronary vascular resistances.
Main Results:
- The balloon type exhibited high flow velocity and pressure but no leakage.
- The fenestrated type demonstrated substantial leakage, particularly with smaller ostia.
- The KMS type showed lower flow velocity and pressure with reduced leakage.
- Crucially, only the KMS-type cannula successfully infused fluid into all ostium sizes under counterpressure.
Conclusions:
- The KMS-type coronary perfusion cannula demonstrates superior performance in minimizing leakage and ensuring secure cardioplegic solution delivery.
- Its design may be advantageous for achieving effective myocardial perfusion in patients with diseased coronary ostia.